Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Urinary Bladder Cancer, Muscle-invasive”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT03518320
What this trial is testing

Safety and Tolerability of TAR-200 and Nivolumab in Subjects With Muscle-Invasive Bladder Cancer

Who this might be right for
Bladder Cancer TNM Staging Primary Tumor (T) T2Bladder Cancer TNM Staging Primary Tumor (T) T2ABladder Cancer TNM Staging Primary Tumor (T) T2B+6 more
Taris Biomedical LLC 13
Testing effectiveness (Phase 2)Looking for participantsNCT06637423
What this trial is testing

A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients With Bladder Cancer (MK-2870-027)

Who this might be right for
Non-Muscle Invasive Bladder Cancer
Merck Sharp & Dohme LLC 32
Large-scale testing (Phase 3)Looking for participantsNCT06319820
What this trial is testing

Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer

Who this might be right for
Non-Muscle Invasive Bladder Neoplasms
Janssen Research & Development, LLC 641
Not applicableLooking for participantsNCT05123625
What this trial is testing

Prognostic Effect of Whether Doing PLND During RC for High-risk NMIBC

Who this might be right for
Bladder Cancer
The First Affiliated Hospital with Nanjing Medical University 200
Testing effectiveness (Phase 2)Active Not RecruitingNCT02845323
What this trial is testing

Neoadjuvant Nivolumab With and Without Urelumab in Cisplatin-Ineligible or Chemotherapy-refusing Patients With Muscle-Invasive Urothelial Carcinoma of the Bladder

Who this might be right for
Urothelial CarcinomaBladder Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 15
Not applicableEnded earlyNCT04142359
What this trial is testing

PK Sub-Study of QUILT-3.032 (CA ALT-803-01-16) and of QUILT-2.005 (CA ALT-803-01-14)

Who this might be right for
Pharmacokinetics
Altor BioScience 1
Testing effectiveness (Phase 2)Study completedNCT02844816
What this trial is testing

Atezolizumab in Treating Patients With Recurrent BCG-Unresponsive Non-muscle Invasive Bladder Cancer

Who this might be right for
Recurrent Bladder Urothelial CarcinomaStage 0a Bladder Urothelial Carcinoma AJCC v6 and v7Stage 0is Bladder Urothelial Carcinoma AJCC v6 and v7+1 more
National Cancer Institute (NCI) 172
Testing effectiveness (Phase 2)Study completedNCT03081858
What this trial is testing

Proliposomal Intravesical Paclitaxel for Treatment of Low-Grade, Stage Ta, Non Muscle Invasive Bladder Cancer

Who this might be right for
Bladder Cancer Cell TransitionalNon-Muscle Invasive Bladder CancerBladder Cancer+7 more
Lipac Oncology LLC 15
Testing effectiveness (Phase 2)Looking for participantsNCT06800963
What this trial is testing

ResQ133A-NMIBC: Intravesical Recombinant Mycobacterium (rMBCG) in Participants With NMIBC Eligible to Receive Intravesical Tice BCG

Who this might be right for
NMIBC
ImmunityBio, Inc. 40
Not applicableLooking for participantsNCT04564781
What this trial is testing

Predicting BCG Response

Who this might be right for
Bladder Cancer
Cedars-Sinai Medical Center 400
Not applicableLooking for participantsNCT07187635
What this trial is testing

Guiding Value of Urinary Tumor DNA Testing in Repeat Transurethral Resection of Non-Muscle-Invasive Bladder Cancer

Who this might be right for
Bladder CancerLiquid BiopsyRepeat Transurethral Resection of Bladder Tumor
Tianjin Medical University Second Hospital 196
Testing effectiveness (Phase 2)Active Not RecruitingNCT04186013
What this trial is testing

Efficacy of Atezolizumab Concurrent With Radiotherapy in Patients With Muscle-invasive Bladder cáncer

Who this might be right for
Bladder Cancer
Spanish Oncology Genito-Urinary Group 39
Early research (Phase 1)WithdrawnNCT04972253
What this trial is testing

Phase I BLASST-3 Trial

Who this might be right for
Bladder Transitional Cell CarcinomaBladder CancerFibroblast Growth Factor Receptor
Guru P. Sonpavde
Large-scale testing (Phase 3)UnknownNCT04736394
What this trial is testing

Evaluate the Safety and Efficacy of APL-1202 as a Single-agent Oral Treatment Versus Intravesical Instillation of Epirubicin Hydrochloride in naïve Intermediate-risk NMIBC Patients

Who this might be right for
Non-muscle Invasive Bladder Cancer
Jiangsu Yahong Meditech Co., Ltd aka Asieris 800
Large-scale testing (Phase 3)Active Not RecruitingNCT03732677
What this trial is testing

Durvalumab+ Gemcitabine/Cisplatin (Neoadjuvant Treatment) and Durvalumab (Adjuvant Treatment) in Patients With MIBC

Who this might be right for
Muscle Invasive Bladder Cancer
AstraZeneca 1,063
Testing effectiveness (Phase 2)Study completedNCT00595088
What this trial is testing

Phase 2b, Trial of Intravesical DTA-H19/PEI in Patients With Intermediate-Risk Superficial Bladder Cancer

Who this might be right for
Superficial Bladder Cancer
Anchiano Therapeutics Israel Ltd. 47
Testing effectiveness (Phase 2)Looking for participantsNCT07717242
What this trial is testing

Sun Yat-Sen Treatment Strategy for Enhancing Response in Muscle-invasive Bladder Cancer

Who this might be right for
Bladder Urothelial CarcinomaBladder Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 80
Large-scale testing (Phase 3)Not Yet RecruitingNCT07756008
What this trial is testing

Bladder-Sparing Treatment With Disitamab Vedotin and Toripalimab With or Without Pelvic Lymph Node Dissection in Bladder Cancer

Who this might be right for
Bladder Urothelial CarcinomaMuscle-invasive Bladder CancerBladder Cancer
Tianjin Medical University Second Hospital 114
Not applicableUnknownNCT01198808
What this trial is testing

Tumorspecific T-cell Immunity in Bladder Cancer as Prognostic Marker

Who this might be right for
Bladder Cancer
Technical University of Munich 50
Not applicableLooking for participantsNCT05464576
What this trial is testing

Tumor Staging T of Bladder Tumours: Correlation of MRI and Anatomopathologic Analysis

Who this might be right for
Urinary Bladder TumourMRIInvasion+1 more
University Hospital, Clermont-Ferrand 150
Next Page